• Publications
  • Influence
Perception and practice of sublingual immunotherapy among practicing allergists in the United States: A follow-up survey.
BACKGROUND Limited information is available regarding the current perception and practice of sublingual immunotherapy (SLIT) use among US and international allergists. In light of 4 recent US FoodExpand
  • 3
  • 1
Scribes, EHRs, and Workflow Efficiencies in Allergy Practices
TLDR
In the ever-changing healthcare system, along with new advancements in the field of allergy, the workflow for the allergist continues to evolve requiring more time spent doing non-clinical duties such as documentation and reviewing reimbursement challenges. Expand
  • 1
Are Allergen Immunotherapy Dose Adjustments Needed for Local Reactions, Peaks of Season, or Gaps in Treatment?
INTRODUCTION We have been asked to debate the merits of dose adjustments for local reactions (LRs), pollen seasons, and gaps in therapy for subcutaneous allergen immunotherapy (SCIT). As allergistsExpand
  • 1
SCIT Adherence: Making IT Happen!
  • 1
Clinical Aspects of Sublingual Immunotherapy Tablets and Drops.
OBJECTIVE Sublingual immunotherapy (SLIT) is administered via tablets (SLIT-T) or liquid drops (SLIT-D). In North America, currently four SLIT-T formulations are FDA approved for allergyExpand
  • 1
Recombinant zoster vaccine administration in an allergy/immunology practice: a medical and economic case.
  • 1
PERCEPTION AND PRACTICE OF SUBLINGUAL IMMUNOTHERAPY AMONG PRACTICING ALLERGISTS IN THE US: 2018 FOLLOW-UP SURVEY.
Introduction Limited information regarding current trends of sublingual immunotherapy (SLIT) use in the United States and perception of SLIT relative to 2007 and 2013 is available, especially inExpand
Immunotherapy and systemic reactions.